Background. Computed tomography (CT) has been used in the assessment of pediatric hearing loss, but concern regarding radiation risk and increased utilization of magnetic resonance imaging (MRI) have prompted us toward a more quantitative and sophisticated understanding of CT's potential diagnostic yield.
Introduction
Hearing loss is a regularly encountered pediatric problem with significant implications for childhood development. Approximately 9% to 16% of school-age children are affected by some form of hearing impairment, [1] [2] [3] [4] and studies of affected students have shown that they are prone to significantly worse academic performance, behavior, and self-esteem than their normal hearing peers. 1, [5] [6] [7] [8] The diagnostic assessment of pediatric hearing loss may involve a range of studies, such as genetic testing, electrocardiogram, and imaging evaluation. Imaging has classically been performed with computed tomography (CT), 9 which has the capacity to identify anomalies of the cochlea, vestibular aqueduct, and other key aspects of the temporal bone. Concerns regarding the attendant radiation exposure have been raised, refuted, and debated in public forums such as the New York Times and Newsweek, [10] [11] [12] bringing into question what role CT should have in the evaluation of our affected youth (Paul H. Ellenbogen, MD, FACR, e-mail communication, April 7, 2014) . More recently, magnetic resonance imaging (MRI) has also been used in the evaluation of infants and children with hearing loss, 13 either in concert with or in lieu of CT. The decision to use either or both modalities is multifaceted 14 and ideally involves a thorough understanding of the unique benefits and risks associated with each option.
Diagnostic test selection involves a variety of factors, including the clinical pretest probabilities, diagnostic yield, potential harms, and additional available test options. Accordingly, the decision to pursue a CT scan for pediatric hearing loss involves an understanding of not only the specific patient characteristics but also (1) the expected diagnostic yield, (2) the potential risks of the attendant radiation, and (3) the additionally available imaging options. Specific patient characteristics, such as whether hearing loss occurs in isolation or with other clinical findings, as well as the type, severity, and laterality of the impairment, may also influence the decision. 13, 14 In addition, the clinical implications of potentially expected findings play a role. Our overarching goal was thus to investigate the 3 aspects listed above, so as to provide caregivers with concrete, evidence-based information upon which to base the decision to obtain a CT scan in the setting of pediatric hearing loss. Systematic reviews provide a rigorous method to evaluate the current best evidence regarding a specific clinical question and are among the highest levels of evidence available. [15] [16] [17] The objective of the current systematic review was to evaluate the first of the 3 enumerated concepts above, in order to support decisions regarding CT in pediatric patients with hearing loss (sensorineural, mixed, or conductive). More specific, the goal of this systematic review was to determine (1) the prevalence of imaging-identified diagnoses in those undergoing CT for hearing loss, (2) subgroup-specific diagnostic yield according to hearing severity and laterality, and (3) the prevalence of specific diagnoses among those with abnormal findings on CT.
Methods
A computerized search was performed to focus on the diagnostic yield of CT scan for infants, children, and adolescents with hearing loss. Computerized and manual searches were performed to identify all relevant data. A PubMed search of MEDLINE from 1966 to December 2013 was performed. Articles that mapped to the medical subject heading "tomography, X-ray computed" (exploded) and those that mapped to keywords "computed tomography" were collected into a first group. Next, articles mapping to the exploded medical subject headings "hearing loss," "ear, inner/diagnosis," "ear, inner/ pathology," and "ear, inner/radiography" as well as the keyword "hearing" were collected into a second group. Articles that mapped to the exploded medical subject headings "child" and "infant" and those that mapped to the keywords "pediatric" and "newborn" were then collected into a third group. The 3 groups were then cross-referenced (Appendix S1, available at http://otojournal.org) and limited to those with human subjects and English language. Case reports as defined by the database's publication type variable "case reports" were excluded. 18 Two independent searches were performed by individuals blinded to the others' results. In addition, searches with corresponding terms were repeated in EMBASE and the Cochrane Library to December 2013. In accordance with standard systematic review techniques, all journals indexed to these databases were included by default, thus spanning the range of all available impact factors.
This initial computerized search yielded a total of 794 studies. The abstracts were evaluated according to the inclusion/ exclusion criteria described below. Reference lists from criteria-meeting publications and narrative reviews were manually searched for additional studies, yielding 53 additional potential articles. Experts in the field were contacted for any additional reports of published or unpublished data. Titles and abstracts for all identified studies were reviewed, and ultimately, 379 full articles were evaluated (Figure 1 and Figure 2 ).
Inclusion/Exclusion Criteria
Articles identified by the search strategy described above were evaluated to identify those that met the following inclusion criteria: (1) patient population younger than 21 years with unilateral, bilateral, conductive, mixed, or sensorineural hearing loss (SNHL); (2) CT temporal bone or head performed for the purpose of diagnosing or guiding management of hearing loss; and (3) outcome measured in terms of the proportion of those undergoing CT in which the imaging establishes a diagnosis of a temporal bone anomaly or further delineates the specific types of anomalies identified. Prospective, retrospective, and comparative studies as well as case series were included. Articles were excluded if (1) patients were older than 21 years; (2) hearing results were not delineated; (3) hearing loss was temporary; (4) no CT of the temporal bone or head was performed; (5) CTs were obtained for reasons not associated with hearing loss; (6) the cause of hearing loss in the study population had already been previously fully identified; (7) syndromic patient population; (8) no quantitative data were presented; and (9) isolated case reports. Case reports were defined according to a standard definition of a "single clinical observation whose principal purpose is to generate hypotheses regarding human disease or provide insight into clinical practice." 19, 20 This process yielded 50 studies that met our inclusion criteria.
Manual Search
In general, a computerized search has limitations, particularly if the topic assessed is diagnosis. The sensitivity and specificity of the best single term and combinations for high sensitivity MEDLINE searches are just 0.80 and 0.77, respectively. 21 Accordingly, a systematic review standardly includes a manual search to supplement the computerized inquiry. 22 The manual search for this query resulted in 53 titles and 5 additional criteria-meeting papers, as depicted in the more detailed flow charts in Figure 2 . Considering that 50 criteriameeting studies were included in the end, the number of papers identified by manual search falls within expected parameters, given the sensitivity and specificity described above.
Data Extraction
Data extraction additionally focused on potential sources of heterogeneity or bias among those results and study identification (author, year of publication, full reference citation). Extracted data included (1) the number/percentage of patients with CT scans that revealed a new diagnosis of temporal bone anomaly, (2) the number/percentage of subsets of specific types of anomalies identified by CT, (3) consecutive or nonconsecutive status of reported patients, and (4) the mean follow-up time. Also collated were (1) age at CT, (2) the extent of hearing loss in patients studied, (3) types of hearing loss studied (mild, moderate, severe, profound, unspecified; bilateral or unilateral; sensorineural, mixed, or conductive), and (4) study design with potential confounders. Two reviewers corroborated extracted data independently using standardized tables. In accordance with data demonstrating that overall "study quality" ranking scales may be misleading or give heterogeneous results, [23] [24] [25] [26] we focused on evaluation of data quality by consistent factual description of individual elements of study design with attention to prospective/retrospective analysis and assessment of consecutive patients.
Quantitative Data Analysis
The extracted data were analyzed for heterogeneity to determine if pooling of data would be appropriate. Data were examined in subsets according to clinical hearing loss characteristics: severe to profound, bilateral, unilateral, and no conductive/mixed component. Studies of children with severe, bilateral hearing loss were included in both related subsets. Diagnostic yield was defined as the proportion of patients affected according to the defined imaging modality: yield = (number of patients with imaging-established diagnoses) / (number of patients imaged). Nearly all studies reported their findings per patient, but in the minority instance when it was reported per ear, the data were nonetheless included in the systematic review and numerical analyses in the translated per-patient increment, since the decision to image is made at the level of the patient, rather than 1 ear at a time. In the single instance where data were reported solely on a per-ear basis, 27 these data were withheld from the aggregate analyses so as to not confound the per-patient measurement.
For counts of all diagnoses, any reported CT finding made by the imaging modality indicated was enumerated, also at the patient level. Thus, every effort was made to (1) ideally use a composite total number of affected patients from the primary report, and (2) account for the potential for overlapping diagnoses in a single patient when 1 was not provided. For this latter reason, if the affected number of patients was reported such that it was unclear whether the findings did or did not overlap within the same patients, the individual numbers were not simply summed to establish a total. In the case where more than 1 system was used to evaluate a single diagnosis in the same subset of patients, the system that the authors espoused in conclusion was used in the analysis. 28 Heterogeneity among studies was evaluated using the I 2 statistic, which is a measure of the variation between studies that exceeds that from chance alone. Perfectly homogeneous studies have a theoretical I 2 value of 0%. The range from 0% to 40% is thought to represent unimportant heterogeneity, whereas the overlapping values of 30% to 60% and 50% to 90% have been postulated to represent moderate and substantial heterogeneity, respectively. 29, 30 Since the number of studies in subgroup analyses was often small or results were notably variable, 95% confidence or "uncertainty" intervals were calculated. 31 An a priori plan was made to pool data for a formally presented meta-analysis in the instance where the group/subgroup's point estimate for I 2 was < 60% and the 95% confidence interval (CI) overlapped by 0% to 40%.
Meta-analyses were performed using a random effects analysis, according to the standard technique of DerSimonian and Laird 32, 33 to obtain a weighted pooled risk difference or pooled proportion. Statistical analyses and calculations were performed in Stata 12.0 (College Station, Texas, USA), Medcalc (Ostend, Belgium), and Microsoft Excel (Redmond, Washington, USA). Since no group or subgroup analyses met the a priori heterogeneity threshold described above, the data for meta-analysis are not formally presented in full (ie, with forest plots and tables for each subset), as their pooled accuracy is less certain. 34, 35 The aggregate estimates are, however, presented in tabular format for reader interest, with the associated due caution in the setting of notable heterogeneity.
Results

Study Characteristics
The 50 criteria-meeting studies relevant to the diagnostic yield of CT scans for temporal bone anomalies included a total of 5757 subjects. 27, 28, Forty-one studies were retrospective case series. The remaining studies included prospective case series, 36,37,56,57 1 prospective cohort study, 55 1 case-control study, 48 1 cross-sectional study, 27 1 study with both prospectively and retrospectively recruited patients, 83 and 1 historical inception study. 58 Fourteen restricted their analyses to patients with severe to profound SNHL ( Table 1) . Eleven studies included only patients with bilateral hearing loss (Appendix S2, available at http://otojournal.org), and 7 studies included only patients with unilateral hearing loss ( Table 2) . Twenty-seven studies did not specify or categorize the types of hearing loss of patients studied ( Table 3) .
Heterogeneity among studies was large (I 2 = 90%; 95% CI, 89%-92%), such that interpretation of pooled data for the entire group of publications should be done with caution. For reader interest, however, the overall data are demonstrated in a forest plot (Figure 3) , and the pooled diagnostic yield (random effects) is noted to be 30% (95% CI, 26%-34%). The heterogeneity among studies as calculated by I 2 remained substantial, even when stratified by study characteristics and severity, laterality, or type (conductive/mixed/sensorineural) of hearing loss ( Table 4 ). In the setting of substantial heterogeneity, pooled data should be viewed with caution 34 but are presented for the overarching data set to help provide a visual summary of the body of relevant studies.
Severe to Profound Hearing Loss
Fourteen studies specifically evaluated the yield of diagnostic CT in pediatric patients with severe to profound SNHL ( Table 1 ). The percentage of CT scans of patients with profound hearing loss that revealed new diagnoses of temporal bone anomalies ranged from 16% 18 to 74%. 43 The 2 prospective studies found that 43% (19/44) 37 or 49% (33/67) 36 of patients had diagnostically valuable CT scans. Nine of 14 studies had consecutive patients, with the same range of diagnostic yield. Ten of 14 studies limited their patients to cochlear implant candidates or patients who had already received cochlear implants and reported the same range. Among the 4 remaining studies of patients with severe to profound SNHL of unknown etiology, the study with the largest sample size found that 18% (43/245) had diagnostically valuable CT scans. 42 The 2 studies that reported the highest diagnostic yields were among those with the smallest sample sizes: 74% (25/34) 43 and 70% (7/10). 48 Overall, the most common diagnostic findings on CTs of patients with profound hearing loss were enlarged vestibular aqueduct (EVA) and cochlear dysplasia.
Bilateral Hearing Loss
Eleven studies evaluated CT findings in infants and children with bilateral HL (Appendix S2). Nine of these had patients with cochlear implants and are thus represented in the subsets of both Table 1 and Appendix S2. The percentage of CT scans of patients with bilateral hearing loss that revealed new diagnoses ranged from 10% 81 to 74%. 43 Nine of 11 studies had consecutive patients with the same diagnostic range.
There was a single prospective study, which reported a diagnostic yield of 49% (33/67). 15 The most common findings associated with profound hearing loss were EVAs and cochlear dysplasias or malformations. The 2 reports not restricted to cochlear implant candidates 81, 82 included patients with the range of mild to profound hearing loss and demonstrated a 10% and 28% yield, respectively, of new diagnoses identified via CT scan. 
Unilateral Hearing Loss
In 7 case series of patients with unilateral hearing loss, the primary outcome measure was the proportion of patients who received CTs that diagnosed new temporal bone anomalies ( Table 2) . Six retrospective studies evaluated consecutive patients; the seventh study 83 included both prospective and retrospective patients. The percentage yield ranged from 18% 53 to 67%. 50 Song et al 49 had the largest study population (n = 322) and reported a 29% diagnostic rate. Each of the remaining retrospective case series had n = 69 patients or fewer. Across all 7 studies, 45% 83 to 76% 49 of patients had profound hearing loss or worse. In these studies of unilateral hearing loss, the most common CT-established diagnoses included EVA, cochlear malformation, and atypical internal auditory canal (IAC).
Unspecified/Uncategorized/Range of Types of Hearing Loss
Twenty-seven studies either did not specify the range of hearing loss studied or studied a wide range of types of hearing loss ( Table 3) . Twenty-one studies reported results for consecutive patients. Three studies had nonconsecutive patients, 27, 63, 74 and 3 studies did not report the consecutive status of patients. 67, 75, 80 Among all studies, the percentage of newly diagnosed temporal bone anomalies ranged from 7% 75 to 64%. 79 One study followed a prospective cohort and found a 30% diagnostic yield with no significant difference in CT findings according to severity of SNHL. 55 Two smaller prospective case series with consecutive patients reported yields of 27% 56 and 22%, 57 and 1 historical inception cohort There is a statistically significant difference between SNHL and non-SNHL groups. 
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Otolaryngology-Head and Neck Surgery 151 (5) reported a yield of 26%. 58 One cross-sectional study of CTs in patients with SNHL compared to those with normal hearing found statistically significant differences in percentages of ears diagnosed with (1) narrow IAC, (2) EVA, and (3) cochleovestibular abnormalities. 27 Across all studies, the most common diagnoses were EVA and cochlear anomalies.
Prospective Data
Of the 50 studies examined, only 5 used a prospective study design. The largest was reported by Preciado et al 55 36, 37, 55, 57 determined that EVA was the most common diagnostic entity, whereas 1 study 56 did not report the specific types of anomalies identified. Preciado et al 55 reported that there were no statistically significant differences in diagnostic yields of CT for patients of different levels and types of hearing loss.
Enlarged Vestibular Aqueduct
Enlarged vestibular aqueduct was the most common diagnosis in 25 out of 50 studies. Four studies reported solely EVA findings. 28, 60, 62, 78 The largest prospective study reported that 16% of pediatric patients with hearing loss of unknown etiology were diagnosed with EVA via CT scan. 55 Other studies showed that EVA accounted for as many as 75% of abnormal CT findings. 51 The aggregate data were analyzed for heterogeneity, which was substantial even when this diagnosis alone was considered, I 2 = 91% (95% CI, 89%-93%) ( Table 4 ). This heterogeneity remained high even when the EVA diagnosis alone was analyzed in the subgroup defined by severe to profound hearing loss (I 2 = 96%; 95% CI, 94%-97%). When EVA was evaluated in the subset of unilateral hearing loss, heterogeneity was less (I 2 = 67%; 95% CI, 27%-85%), which was the lowest among all of the study subgroups but still notable. Among this subset, the pooled data reflected a diagnostic yield of 11% (95% CI, 7%-17%).
A sensitivity analysis for the EVA subset was performed, as 1 study evaluated 2 different criteria for EVA diagnosis/measurement in the same patient population. 28 Regardless of whether the Cincinnati or Valvassori criteria were used for that study in the aggregate analysis, the composite data showed similar results.
Narrow Cochlear Nerve Canals/Internal Auditory Canals
Diagnoses of narrow, stenotic, small, or absent cochlear nerve canals (CNC) or IACs were described in 31 out of 50 studies. Overall, the reported diagnostic yield of CT scan for narrow CNC or IAC in pediatric patients ranged from 0% to 54%. 50 Figure 3 . Forest plot of the diagnostic yield for all studies, all diagnostic findings. The wide range of data is demonstrated. The pooled proportion yield should be interpreted with caution due to the substantial heterogeneity among studies. This pooled estimate is thus presented for interest but not as a meaningful single estimate of the effects of the studies, given the heterogeneity observed ( Table 4 ). The studies are presented in an order that parallels the order in the tables presenting the remainder of the results (prospective precedes retrospective; severe to profound and bilateral precedes unilateral and unspecified).
The largest studies showed a 4% to 7% prevalence of this finding. 38, 49 Heterogeneity among these studies was high, regardless of whether subsets of severe to profound or unilateral hearing loss were considered ( Table 4) . For reader interest, it is noted that the pooled data for the narrow CNC subset was 4% (3%-7%), although again these aggregate data should be viewed with some caution.
Discussion
The data from this systematic review demonstrate a wide range of diagnostic yields in temporal bone CTs (7% 75 to 74% 43 ) obtained for pediatric hearing loss. The largest prospective study and aggregate data show a 30% yield for all diagnoses combined. 55 This yield suggests that in order to obtain 1 new diagnostic result, 4 patients need to undergo CT 55 (range, 2-15). 43, 75 Certain diagnoses may alter the management strategy for the presenting patient and were therefore considered in more detail in our analysis. More specific, although controversial, some practitioners may instruct families of children with EVA to avoid contact sports or other activities with an inherent risk of head trauma. 84 In addition, other providers use the finding of EVA to prompt testing for mutations in the PDS or EYA genes. 85, 86 The strongest data suggested that the diagnostic yield for EVA was 16%. The subset with the least heterogeneity occurred in the circumstance when the diagnosis of EVA was considered exclusively in studies of unilateral hearing loss. Pooled diagnostic yields in the setting of substantial heterogeneity (ie, I 2 > 60%) should be interpreted with caution. b In the quantitative aggregate analysis, "all studies" includes all studies reporting data on a finding per patient basis. One publication 27 reported findings on a per ear basis alone; that publication would have appeared in the groups/subgroups of all studies, all findings, all hearing loss; all studies, all findings, unspecified/ range of hearing loss.
The finding of a narrowed or absent cochlear nerve canal may also affect counseling if cochlear implantation is being considered, as an absent nerve in particular may prompt consideration of alternate interventions such as auditory brainstem implant. A narrowed cochlear nerve canal may additionally suggest that future additional hearing deterioration will be limited, 87 providing valuable prognostic information for the family. The largest studies showed a 4% to 7% diagnostic yield for a narrow CNC, and again, these data had substantial heterogeneity.
When considered in aggregate, these CT data did not suggest that discrete patterns of hearing loss had statistically significant differences in diagnostic yield, although it was suggested in some individual study results. Regardless of whether hearing loss was severe, bilateral, unilateral, sufficient to warrant cochlear implant candidacy, or unspecified, the range of diagnostic yield was wide and heterogeneity was high even within subgroups, making it difficult to draw conclusions about differential evaluation of specific types of hearing loss. Even when studies were limited to subgroups with objectively defined diagnostic criteria, heterogeneity within the group remained high (Appendix S3, available at http://otojournal.org). Prospective studies had the tightest range of diagnostic yield (22%-49%, in comparison with 7%-74% in other studies), which suggests that further prospective analysis with a priori, clearly defined diagnostic criteria may yield more specific data that could guide evaluations specific to the severity, laterality, and type of hearing loss.
The wide range of observed estimates of diagnostic yield for CT scans may be partially attributable to differences in diagnostic criteria used in each study to determine what constitutes specific anomalies. For example, Dewan et al 28 demonstrated that application of the Valvassori criteria (> 1.5 mm at the midpoint) versus the Cincinnati criteria (midpoint or opercular width greater than the 95th percentile) resulted in an approximately 30% difference in rates of EVA diagnosis. In addition, other authors reported using still different criteria for the same diagnosis (eg, > 2 mm), 27 whereas others did not report on their defined criteria at all. Differences in CT equipment and protocols may have also contributed to variability in the reported yields 88 ; included studies used scans of different slice thicknesses (0.625-mm slices 76 to 1-mm slices 69 ) and a variety of levels of radiation (eg, 1 study estimated a mean dose of 29 mGy 54 whereas another estimated doses ranging from 35.55 to 44.44 mGy 76 ).
Regardless, understanding the associated numbers needed to image (ie, number of patients who need to undergo CT in order to yield 1 diagnosis) provides information that may be weighed against the associated numbers needed to harm (ie, the number of patients who need to undergo CT in order for 1 malignancy or other adverse effect to develop), and this latter concept is addressed in a separate systematic review. 89 The most rigorous data from that sister study show that if every excess brain cancer after brain CT were attributable only to the imaging itself, then approximately 1 in 4000 pediatric brain CTs would be followed by a malignancy (mean estimated radiation dose 40 mSv per scan) or 1 brain tumor per 10,000 patients (10 mGy per scan, < 10 years of age at exposure). 90, 91 As temporal bone CT confers a smaller radiation dose than brain CT, the associated risks of radiation are anticipated to be even lower, although direct patient data from temporal bone imaging are very limited. Overall, these data suggest that CT for pediatric hearing loss is more than 1000 times more likely to yield a diagnosis than have a subsequent malignancy. The CT-specific data in the present systematic review also provide a context in which to consider the diagnostic yield of other imaging evaluation options for pediatric hearing loss (ie, MRI). All of these data together form the basis for decisions analysis on a population level 92, 93 as well as for shared, informed decision making [94] [95] [96] with families in circumstances where the risks and benefits of CT are weighed together.
